Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020088614 - USE OF TRYPTANTHRIN DERIVATIVE IN TREATING NERVOUS SYSTEM DISORDERS

Publication Number WO/2020/088614
Publication Date 07.05.2020
International Application No. PCT/CN2019/114857
International Filing Date 31.10.2019
IPC
C07D 487/04 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
487Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/-C07D477/183
02in which the condensed system contains two hetero rings
04Ortho-condensed systems
A61K 31/519 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
519ortho- or peri-condensed with heterocyclic rings
A61K 31/5377 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
535having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
53751,4-Oxazines, e.g. morpholine
5377not condensed and containing further heterocyclic rings, e.g. timolol
A61P 25/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
A61P 25/16 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
14for treating abnormal movements, e.g. chorea, dyskinesia
16Anti-Parkinson drugs
Applicants
  • 苏州如鹰生物医药有限公司 SUZHOU ROEING BIOPHARMACEUTICALS CO., LTD. [CN]/[CN]
Inventors
  • 匡春香 KUANG, Chunxiang
Agents
  • 上海一平知识产权代理有限公司 XU & PARTNERS, LLC.
Priority Data
201811303319.602.11.2018CN
Publication Language Chinese (ZH)
Filing Language Chinese (ZH)
Designated States
Title
(EN) USE OF TRYPTANTHRIN DERIVATIVE IN TREATING NERVOUS SYSTEM DISORDERS
(FR) UTILISATION DU DÉRIVÉ DE TRYPTANTHRINE DANS LE TRAITEMENT DE TROUBLES DU SYSTÈME NERVEUX
(ZH) 色胺酮衍生物治疗神经系统疾病的用途
Abstract
(EN)
A use of a tryptanthrin derivative in treating nervous system disorders. The tryptanthrin derivative has a structure represented by formula (I) below, wherein the definitions of groups are shown in the description. <img file="dest_path_image002aaa.jpg" he="45.51" img-content="drawing" img-format="jpg" inline="yes" orientation="portrait" wi="85.73"/>
(FR)
L'invention concerne l'utilisation d'un dérivé de tryptanthrine dans le traitement de troubles du système nerveux. Le dérivé de tryptanthrine a une structure représentée par la formule (I) ci-dessous, les définitions des groupes étant présentées dans la description. Drawing_references_to_be_translated:
(ZH)
一种色胺酮衍生物治疗神经系统疾病的用途,所述的色胺酮衍生物具有如式(I)所示的结构,其中,各基团的定义如说明书所示。
Latest bibliographic data on file with the International Bureau